MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0118715303280679240206100137

Медицинская библиотека · Endocrine, metabolic & immune disorders drug targets · 2024

Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction.

González María Miguélez, Sanz-Pastor Alba Galdón, Gómez Roberto Áñez, Torrecilla Noemi Brox, Moreno Diego Muñoz, Fernández Laura González, Rivas Alejandra Maricel, Guerra Aurelio López, Álvarez Rosa, Arranz José Ángel, Rodas Iván Márquez, Escudero Vicente, Sanjurjo María, Vallejo Javier Martín, Martín Miguel, Albarrán Olga González

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

The purpose of this study was to identify predictive and risk factors for the development of immune-related endocrinopathies and to analyze the incidence and characteristics of immune-related endocrinopathies in our population.

DESIGN

A retrospective, single-centre cohort carried out at Gregorio Marañón Hospital between January 2018 -December 2019.

METHODS

A total of 163 patients were enrolled. In January 2018 and December 2019, we treated patients who underwent ICI treatment in the Medical Oncology Department of General University Hospital Gregorio Marañón, a tertiary care public hospital in Madrid, as part of an observational, retrospective, single-center cohort study.

RESULTS

Endocrinopathies were diagnosed in 19.5% of the patients (n = 32). The tumours with the highest incidence of endocrinopathies were non-small cell lung cancer (25,9%), kidney cell cancer (25%) and hepatocarcinoma (20%). Among the 32 patients who developed endocrinopathy, 18,8%, 19,13%, and 21,28% received anti-CTLA-4, anti-PD-1 and anti-PDL-1, respectively. Thyroid dysfunction was the most frequent endocrinopathy (12,8%). A higher percentage of patients with negative antiTPO and antiTG antibodies developed G1 hypothyroidism compared to patients with positive antibodies who developed a higher proportion of G2 hypothyroidism. The presence of an initial phase of thyrotoxicity was not related to greater severity. We observed longer progression-free survival in patients who developed thyroid dysfunction.

CONCLUSION

Pre-existing antibodies were independently associated with endocrinopathies. Moreover, our study let us conclude that the presence of thyroid autoantibodies may be related to its severity. It is important to determine anti-thyroid antibodies prior to the start of immunotherapy as a risk factor for thyroid dysfunction, which in turn is a prognostic marker.

Для цитирования: González María Miguélez, Sanz-Pastor Alba Galdón, Gómez Roberto Áñez, Torrecilla Noemi Brox, Moreno Diego Muñoz, Fernández Laura González, Rivas Alejandra Maricel, Guerra Aurelio López, Álvarez Rosa, Arranz José Ángel, Rodas Iván Márquez, Escudero Vicente, Sanjurjo María, Vallejo Javier Martín, Martín Miguel, Albarrán Olga González. Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction.. Endocrine, metabolic & immune disorders drug targets. 2024. DOI: 10.2174/0118715303280679240206100137.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.